首页> 外文会议>Congress of the International Pig Veterinary Society >EVALUATION OF THE USE OF DRAXXIN VET~R TO ELIMINATE MYCOPLASMA HYOPNEUMONIAE AND ACTINOBACILLUS PLEUROPNEUMONIAE SEROTYPE 6 12
【24h】

EVALUATION OF THE USE OF DRAXXIN VET~R TO ELIMINATE MYCOPLASMA HYOPNEUMONIAE AND ACTINOBACILLUS PLEUROPNEUMONIAE SEROTYPE 6 12

机译:评价司司毒素〜R消除支原藓疫苗和Actinobacillus胸膜炎患者血管型6&12

获取原文

摘要

Elimination of Mycoplasma hyopneumoniae (M hyo) and Actinobacillus pleuropneumoniae (Ap) from pig herds has been attempted in different ways and with the use of various antibiotics (1,2, 3). The combination of a modified "Swiss partial depopulation model" and treatment with tulathromycin lOOmg/ ml (Draxxin Vet.) for injection was used in this study in a Danish herd, to investigate whether tulathromycin could be an effective alternative to, for instance, quinolones. The success criterion of this studywas the elimination of M Hyo and Ap 6 and Apl2, confirmed by serologic examinations and resulting in the upgrading of the farm's SPF health status according to Danish SPF standards.
机译:消除从猪群的猪肺炎术(M Hyo)和Actinobacillus pleuropneumoniae(AP)以不同的方式进行了不同的方式,并使用各种抗生素(1,2,3)。在丹麦群中使用改进的“瑞士部分缺失模型”和用杜拉霉素肥大素(Draxxin VET)的治疗方法。在丹麦群中,研究了杜拉莫霉素是否可以是例如喹诺酮类的有效替代品。该研究的成功标准是消除M Hyo和AP 6和APL2,通过血清学检查证实并导致根据丹麦SPF标准进行农场的SPF健康状况升级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号